J
J.E. van der Wal
Researcher at University Medical Center Groningen
Publications - 44
Citations - 1769
J.E. van der Wal is an academic researcher from University Medical Center Groningen. The author has contributed to research in topics: Parotid gland & Salivary gland. The author has an hindex of 22, co-authored 44 publications receiving 1657 citations. Previous affiliations of J.E. van der Wal include University of Groningen & Academic Center for Dentistry Amsterdam.
Papers
More filters
Journal ArticleDOI
Surgical management of 246 previously untreated pleomorphic adenomas of the parotid gland.
TL;DR: A retrospective study compares the results of the different surgical methods with regard to recurrence rate and the effects on morbidity between 1974 and 1994 to find out which methods influenced outcome following parotidectomy.
Journal ArticleDOI
Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome
J. Pijpe,Warner Kalk,J.E. van der Wal,Arjan Vissink,Philippus Kluin,Jan L. N. Roodenburg,Hendrika Bootsma,Cornelis Kallenberg,Frederik Spijkervet +8 more
TL;DR: A parotid biopsy has a diagnostic potential comparable with that of a labial biopsy in the diagnosis of pSS, and may be associated with less morbidity.
Journal ArticleDOI
Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome
J. Pijpe,Jiska Meijer,Hendrika Bootsma,J.E. van der Wal,Frederik Spijkervet,Cornelis Kallenberg,Arjan Vissink,Arjan Vissink,Stephan Ihrler +8 more
TL;DR: Sequential parotid biopsy specimens obtained from patients with primary SS before and after rituximab treatment demonstrated histopathologic evidence of reduced glandular inflammation and redifferentiation of lymphoepithelial duct lesions to regular striated ducts as a putative morphologic correlate of increased parotids flow and normalization of the salivary sodium content.
Journal ArticleDOI
Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjögren’s syndrome and associated MALT lymphoma
J. Pijpe,G. W. van Imhoff,Arjan Vissink,J.E. van der Wal,Philip M. Kluin,Fred K. L. Spijkervet,C. G. M. Kallenberg,Hendrika Bootsma +7 more
TL;DR: This case report is the first to describe the effect of rituximab on histological and sialometric/chemical characteristics of SS, and is a promising agent in the treatment of SS associated MALT lymphoma.
Journal ArticleDOI
The results of CO2 laser surgery in patients with oral leukoplakia: a 25 year follow up.
TL;DR: This large study with a long follow up shows that laser treatment is a good prophylactic treatment for oral leukoplakia.